Rising Pharmaceuticals Warfarin Tablets Recall: Impurities Risk Serious Injury
Rising Pharmaceuticals recalls 100-count Warfarin Sodium tablets (NDC 57237-119-01) due to impurities that could cause serious injury. Affected batches expire April 2023.
Use caution until it’s fixed
Failed Impurities/Degradation Specifications
Contact the company
What happened, in plain English
Rising Pharmaceuticals is recalling 100-count Warfarin Sodium tablets (1 mg) that may contain impurities. This could cause serious injury if taken as directed. Patients should not use these tablets without contacting their doctor. Read more at govinfonow.com/recall/33872-rising-pharmaceuticals-warfarin-tablets-recall-impurities-risk-serious-injury.
Source Summary by GovInfoNow · govinfonow.com/recall/33872-rising-pharmaceuticals-warfarin-tablets-recall-impurities-risk-serious-injury · Updated August 17, 2026 · FDA enforcement record: FDA #D-0348-2023
Cite this page
“Rising Pharmaceuticals Warfarin Tablets Recall: Impurities Risk Serious Injury.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33872-rising-pharmaceuticals-warfarin-tablets-recall-impurities-risk-serious-injury. Based on FDA recall #D-0348-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0348-2023%22&limit=1).
Why it’s dangerous
Warfarin tablets may contain impurities that affect blood clotting. This could lead to serious bleeding or clotting issues if taken as directed.
Who’s affected
People prescribed warfarin who own the recalled tablets. Those with blood clotting conditions are most at risk.
How to tell if you have this one
Check for the 100-count bottle labeled 'Warfarin Sodium Tablets, USP 1 mg'. The batch number is NB101596 and expiration date is April 30, 2023.
- Brand
Rising Pharmaceuticals- Category
Drug
What to do — step by step
Stop Using Tablets
Immediately stop using the recalled Warfarin tablets if you have them.
Contact Your Doctor
Talk to your healthcare provider about alternative blood thinners.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0348-2023 (February 15, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0348-2023 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.